Marina N. Sharifi, MD, University of Wisconsin Carbone Cancer Center, Madison, WI, highlights some of the key advantages and challenges of adopting the use of ctDNA fragmentation techniques in routine clinical practice, and how it might impact the landscape of precision onclogy and personalized treatment strategies. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.